Sector portfolio · VC firm · United States
General Catalyst's Biotech portfolio
General Catalyst has backed 26 Biotech startups in rounds we track, $3.2B between them, shown by the stage each has reached. The best-funded is Pathai.
General Catalyst's whole portfolioGeneral Catalyst's profile
Funding by segment
- Stage not reported$1.0B9
- Series C and later$1.7B8
- Series A$271M5
- Series B$251M4
Where they are based
- United States24$3.0B
- Canada2$184M
United States
CanadaFounded
3 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M1
- $10M to $50M6
- $50M to $250M15
- $250M to $1B4
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
22 of 26 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States24
- Canada2
Startups by country, 2 countries in all.
Segment by segment
Stage not reported
9 startups · $1.0B raised
Dren BioDren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.United States$375M
ArriVentArriVent develops pharmaceutical products to cure presently untreatable cancer.United States$325M
Rakuten MedicalRakuten Medical, Inc.United States$109M
ZagenoZAGENO is an enterprise marketplace solution that connects e-commerce to life science.United States$61M
Fractyl HealthFractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.United States$60M
Ossium HealthOssium Health is a bioengineering and therapeutics company based in San Francisco, California, founded in 2016.United States$52M
MirvieMirvie is a biotechnology company based in South San Francisco, California, focused on improving pregnancy health through early deUnited States$24M- CCuraiUnited States$11M
Series C and later
8 startups · $1.7B raised
PathAIPathAI develops technology that assists pathologists in making accurate diagnoses for every patient, every time.United States$400M
Eikon TherapeuticsEikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.United States$351M
Odyssey TherapeuticsOdyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.United States$238M
Dewpoint TherapeuticsDewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.United States$196M
Alpha-9 OncologyAlpha-9 Oncology is a clinical-stage radiopharmaceutical company focused on developing targeted treatments for cancer.Canada$175M- OOM1United States$171M
Truvian SciencesTruvian Sciences develops an automated benchtop system to provide lab-accurate blood testing results.United States$101M- FFractylUnited States$44M
Series A
5 startups · $271M raised
RomanRoman is a manufacturer and distributor of Christmas items and gift products.United States$88M- CGColor GenomicsUnited States$60M
Enable MedicineEnable medicine is a biotechnology company that develops biological cartography tools to generate cellular maps that help in drug discovery.United States$60M
Waypoint BioWaypoint Bio is a biotechnology startup based in New York City, founded in 2021.United States$35M
drchronoThe essential platform for modern medical practices to make care more informed, more interactive, and more personalized.United States$28M
Series B
4 startups · $251M raised
Variant BioVariant Bio is a biotechnology company based in Seattle, founded in 2018.United States$105M
VialScalable biotech advancing clinical programs with cost-effective trials and computationally designed therapeutics.United States$67M
EvvyEvvy is a women's health technology company based in New York, focused on addressing the gender health gap through precision medicine.United States$54M
Elysium HealthElysium Health is a New York-based manufacturer of dietary supplements and consumer health products, focused on translating scientUnited States$25M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names General Catalyst as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like General Catalyst?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.